Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 300

1.

Cost-utility analysis of lifestyle interventions to prevent type 2 diabetes in women with prior gestational diabetes.

Werbrouck A, Schmidt M, Putman K, Annemans L, Benhalima K, Simoens S, Verhaeghe N.

Eur J Public Health. 2019 Oct 30. pii: ckz196. doi: 10.1093/eurpub/ckz196. [Epub ahead of print]

PMID:
31665267
2.

Universal Mental Health Interventions for Children and Adolescents: A Systematic Review of Health Economic Evaluations.

Schmidt M, Werbrouck A, Verhaeghe N, Putman K, Simoens S, Annemans L.

Appl Health Econ Health Policy. 2019 Oct 12. doi: 10.1007/s40258-019-00524-0. [Epub ahead of print] Review.

PMID:
31605299
3.

Opinions of general and adult congenital heart disease cardiologists on care for adults with congenital heart disease in Belgium: a qualitative study.

Willems R, de Hosson M, De Backer J, Annemans L.

Cardiol Young. 2019 Nov;29(11):1368-1374. doi: 10.1017/S1047951119002245. Epub 2019 Sep 6.

PMID:
31489832
4.

PCSK9 inhibition, atherosclerotic cardiovascular disease, and health economics: Challenges at the crossroads.

Annemans L, Stock JK, Chapman MJ.

J Clin Lipidol. 2019 Jul 24. pii: S1933-2874(19)30237-5. doi: 10.1016/j.jacl.2019.07.005. [Epub ahead of print] Review.

PMID:
31427270
5.

Correction: Osteopathic care for spinal complaints: A systematic literature review.

Verhaeghe N, Schepers J, van Dun P, Annemans L.

PLoS One. 2019 Aug 8;14(8):e0221140. doi: 10.1371/journal.pone.0221140. eCollection 2019.

6.

The Use of Computer Simulation Modeling to Estimate Complications in Patients with Type 2 Diabetes Mellitus: Comparative Validation of the Cornerstone Diabetes Simulation Model.

Su ZT, Bartelt-Hofer J, Brown S, Lew E, Sauriol L, Annemans L, Grima DT.

Pharmacoecon Open. 2019 Jun 28. doi: 10.1007/s41669-019-0156-x. [Epub ahead of print]

7.

Effectiveness of an in-home respite care program to support informal dementia caregivers: A comparative study.

Vandepitte S, Putman K, Van Den Noortgate N, Verhaeghe S, Annemans L.

Int J Geriatr Psychiatry. 2019 Oct;34(10):1534-1544. doi: 10.1002/gps.5164. Epub 2019 Jul 11.

PMID:
31243801
8.

A proposal for value informed, affordable ("via") prices for innovative medicines.

Annemans L.

J Med Econ. 2019 Nov;22(11):1235-1239. doi: 10.1080/13696998.2019.1632203. Epub 2019 Jul 8. No abstract available.

PMID:
31199174
9.

Advances in health economic models and outcomes: a necessary condition to make advances in healthcare policy.

Annemans L.

J Med Econ. 2019 Jun;22(6):499-500. doi: 10.1080/13696998.2019.1617162. No abstract available.

PMID:
31070484
10.

Real-world healthcare utilization in adult congenital heart disease: a systematic review of trends and ratios.

Willems R, Werbrouck A, De Backer J, Annemans L.

Cardiol Young. 2019 May;29(5):553-563. doi: 10.1017/S1047951119000441. Epub 2019 May 3.

PMID:
31046858
11.

A model-based economic evaluation of four newborn screening strategies for cystic fibrosis in Flanders, Belgium.

Schmidt M, Werbrouck A, Verhaeghe N, De Wachter E, Simoens S, Annemans L, Putman K.

Acta Clin Belg. 2019 Apr 22:1-9. doi: 10.1080/17843286.2019.1604472. [Epub ahead of print]

PMID:
31007159
12.

Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe.

Kotseva K, Gerlier L, Sidelnikov E, Kutikova L, Lamotte M, Amarenco P, Annemans L.

Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157. doi: 10.1177/2047487319834770. Epub 2019 Apr 6.

PMID:
30955367
13.

Direct Medical Costs of Pediatric Congenital Heart Disease Surgery in a Belgian University Hospital.

Willems R, Tack P, François K, Annemans L.

World J Pediatr Congenit Heart Surg. 2019 Jan;10(1):28-36. doi: 10.1177/2150135118808747.

PMID:
30799714
14.

The combined impact of dependency on caregivers, disability, and coping strategy on quality of life after ischemic stroke.

Dewilde S, Annemans L, Lloyd A, Peeters A, Hemelsoet D, Vandermeeren Y, Desfontaines P, Brouns R, Vanhooren G, Cras P, Michielsens B, Redondo P, Thijs V.

Health Qual Life Outcomes. 2019 Feb 7;17(1):31. doi: 10.1186/s12955-018-1069-6.

15.

Multicolumn spinal cord stimulation for predominant back pain in failed back surgery syndrome patients: a multicenter randomized controlled trial.

Rigoard P, Basu S, Desai M, Taylor R, Annemans L, Tan Y, Johnson MJ, Van den Abeele C, North R; PROMISE Study Group.

Pain. 2019 Jun;160(6):1410-1420. doi: 10.1097/j.pain.0000000000001510.

16.

Impact of palliative home care support on the quality and costs of care at the end of life: a population-level matched cohort study.

Maetens A, Beernaert K, De Schreye R, Faes K, Annemans L, Pardon K, Deliens L, Cohen J.

BMJ Open. 2019 Jan 21;9(1):e025180. doi: 10.1136/bmjopen-2018-025180.

17.

Long-Term Outcome of Acute Coronary Syndromes in Patients on Chronic Oral Anticoagulants: Data from the EPICOR Study.

Stepinska J, Wojtkowska I, Annemans L, Danchin N, Pocock SJ, de Werf FV, Medina J, Bueno H.

Curr Vasc Pharmacol. 2018 Dec 27. doi: 10.2174/1570161117666181227122355. [Epub ahead of print]

PMID:
30588886
18.

A systematic review on costs and cost-effectiveness of screening and prevention of type 2 diabetes in women with prior gestational diabetes: Exploring uncharted territory.

Werbrouck A, Schmidt M, Putman K, Benhalima K, Verhaeghe N, Annemans L, Simoens S.

Diabetes Res Clin Pract. 2019 Jan;147:138-148. doi: 10.1016/j.diabres.2018.11.012. Epub 2018 Dec 7.

PMID:
30529576
19.

Factors Associated with the Caregivers' Desire to Institutionalize Persons with Dementia: A Cross-Sectional Study.

Vandepitte S, Putman K, Van Den Noortgate N, Verhaeghe S, Mormont E, Van Wilder L, De Smedt D, Annemans L.

Dement Geriatr Cogn Disord. 2018;46(5-6):298-309. doi: 10.1159/000494023. Epub 2018 Nov 19.

PMID:
30453298
20.

Predictors of all-cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry.

Rossello X, Bueno H, Pocock SJ, Van de Werf F, Danchin N, Annemans L, Medina J, Zeymer U.

Clin Cardiol. 2019 Jan;42(1):111-119. doi: 10.1002/clc.23116. Epub 2018 Dec 7.

21.

Osteopathic care for spinal complaints: A systematic literature review.

Verhaeghe N, Schepers J, van Dun P, Annemans L.

PLoS One. 2018 Nov 2;13(11):e0206284. doi: 10.1371/journal.pone.0206284. eCollection 2018. Erratum in: PLoS One. 2019 Aug 8;14(8):e0221140.

22.

The relationship between Home-time, quality of life and costs after ischemic stroke: the impact of the need for mobility aids, home and car modifications on Home-time.

Dewilde S, Annemans L, Peeters A, Hemelsoet D, Vandermeeren Y, Desfontaines P, Brouns R, Vanhooren G, Cras P, Michielsens B, Redondo P, Thijs V.

Disabil Rehabil. 2018 Oct 2:1-7. doi: 10.1080/09638288.2018.1501438. [Epub ahead of print]

PMID:
30274531
23.

Osteopathic care for low back pain and neck pain: A cost-utility analysis.

Verhaeghe N, Schepers J, van Dun P, Annemans L.

Complement Ther Med. 2018 Oct;40:207-213. doi: 10.1016/j.ctim.2018.06.001. Epub 2018 Jun 9.

PMID:
30219451
24.

A school- and community-based intervention to promote healthy lifestyle and prevent type 2 diabetes in vulnerable families across Europe: design and implementation of the Feel4Diabetes-study.

Manios Y, Androutsos O, Lambrinou CP, Cardon G, Lindstrom J, Annemans L, Mateo-Gallego R, de Sabata MS, Iotova V, Kivela J, Martinez R, Moreno LA, Rurik I, Schwarz P, Tankova T, Liatis S, Makrilakis K.

Public Health Nutr. 2018 Dec;21(17):3281-3290. doi: 10.1017/S1368980018002136. Epub 2018 Sep 12.

PMID:
30207513
25.

Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey.

De Smedt D, Annemans L, De Backer G, Kotseva K, Rydèn L, Wood D, Amouyel P, Bruthans J, Cifkova R, De Sutter J, Dolzhenko M, Erglis A, Gotcheva N, Gyberg V, Laucevicius A, Lovic D, Oganov R, Pajak A, Pogosova N, Reiner Ž, Stagmo M, De Bacquer D.

Int J Cardiol. 2018 Dec 1;272:20-25. doi: 10.1016/j.ijcard.2018.06.104. Epub 2018 Jun 28.

26.

Endovascular Training Using a Simulation Based Curriculum is Less Expensive than Training in the Hybrid Angiosuite.

Maertens H, Vermassen F, Aggarwal R, Doyen B, Desender L, Van Herzeele I, Annemans L.

Eur J Vasc Endovasc Surg. 2018 Oct;56(4):583-590. doi: 10.1016/j.ejvs.2018.07.011. Epub 2018 Aug 18.

27.

Health-related costs in a sample of premenopausal non-diabetic overweight or obese females in Antwerp region: a cost-of-illness analysis.

Hens W, Vissers D, Annemans L, Gielen J, Van Gaal L, Taeymans J, Verhaeghe N.

Arch Public Health. 2018 Jul 30;76:42. doi: 10.1186/s13690-018-0285-1. eCollection 2018.

28.

Economic evaluation of S. boulardii CNCM I-745 for prevention of antibioticassociated diarrhoea in hospitalized patients.

Vermeersch SJ, Vandenplas Y, Tanghe A, Elseviers M, Annemans L.

Acta Gastroenterol Belg. 2018 Apr-Jun;81(2):269-276.

PMID:
30024698
29.

Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection.

Marbaix S, Peetermans WE, Verhaegen J, Annemans L, Sato R, Mignon A, Atwood M, Weycker D.

PLoS One. 2018 Jul 6;13(7):e0199427. doi: 10.1371/journal.pone.0199427. eCollection 2018.

30.

Appropriateness of End-of-Life Care in People Dying From COPD. Applying Quality Indicators on Linked Administrative Databases.

De Schreye R, Smets T, Deliens L, Annemans L, Gielen B, Cohen J.

J Pain Symptom Manage. 2018 Oct;56(4):541-550.e6. doi: 10.1016/j.jpainsymman.2018.06.011. Epub 2018 Jun 28.

PMID:
29960021
31.

Resource Use During the Last Six Months of Life Among COPD Patients: A Population-Level Study.

Faes K, Cohen J, Annemans L.

J Pain Symptom Manage. 2018 Sep;56(3):318-326.e7. doi: 10.1016/j.jpainsymman.2018.06.002. Epub 2018 Jun 12.

PMID:
29902554
32.

Hospital financing of ischaemic stroke: determinants of funding and usefulness of DRG subcategories based on severity of illness.

Dewilde S, Annemans L, Pincé H, Thijs V.

BMC Health Serv Res. 2018 May 11;18(1):356. doi: 10.1186/s12913-018-3134-6.

33.

Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.

Zeymer U, Annemans L, Danchin N, Pocock S, Newsome S, Van de Werf F, Medina J, Bueno H.

Eur Heart J Acute Cardiovasc Care. 2019 Mar;8(2):121-129. doi: 10.1177/2048872618769057. Epub 2018 Apr 3.

34.

Strategies for newborn screening for cystic fibrosis: A systematic review of health economic evaluations.

Schmidt M, Werbrouck A, Verhaeghe N, De Wachter E, Simoens S, Annemans L, Putman K.

J Cyst Fibros. 2018 May;17(3):306-315. doi: 10.1016/j.jcf.2018.03.002. Epub 2018 Mar 20. Review.

PMID:
29572018
35.

Achieving estimated health and budget gains through combined HIV prevention: theoretical results require real-world effort.

Vermeersch S, Callens S, De Wit S, Goffard JC, Van Beckhoven D, Annemans L.

Acta Clin Belg. 2018 Apr;73(2):167. doi: 10.1080/17843286.2017.1392091. No abstract available.

PMID:
29560819
36.

The potential health and economic effects of plant-based food patterns in Belgium and the United Kingdom.

Schepers J, Annemans L.

Nutrition. 2018 Apr;48:24-32. doi: 10.1016/j.nut.2017.11.028. Epub 2017 Dec 15.

PMID:
29469016
37.

Resource Use During the Last 6 Months of Life of Individuals Dying with and of Alzheimer's Disease.

Faes K, Cohen J, Annemans L.

J Am Geriatr Soc. 2018 May;66(5):879-885. doi: 10.1111/jgs.15287. Epub 2018 Feb 15.

PMID:
29446066
38.

The health-related social costs of alcohol in Belgium.

Verhaeghe N, Lievens D, Annemans L, Vander Laenen F, Putman K.

BMC Public Health. 2017 Dec 16;17(1):958. doi: 10.1186/s12889-017-4974-4.

39.

'Highest risk-highest benefit' strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies.

Annemans L, Packard CJ, Briggs A, Ray KK.

Eur Heart J. 2018 Jul 14;39(27):2546-2550. doi: 10.1093/eurheartj/ehx710. No abstract available.

40.

Further approaches to reduce the cost of renal replacement therapy.

Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, Morton RL, Oberbauer R, Postma MJ, Tonelli M, Van Biesen W, Zoccali C; European Kidney Health Alliance.

Nat Rev Nephrol. 2017 Nov;13(11):720. doi: 10.1038/nrneph.2017.136. Epub 2017 Sep 25. No abstract available.

PMID:
28944776
41.

Development of a prediction model for long-term quality of life in critically ill patients.

Oeyen S, Vermeulen K, Benoit D, Annemans L, Decruyenaere J.

J Crit Care. 2018 Feb;43:133-138. doi: 10.1016/j.jcrc.2017.09.006. Epub 2017 Sep 6.

PMID:
28892669
42.

Variations in hospital costs after traffic injuries: The importance of sociodemographic aspects and comorbidities.

Devos S, Van Belleghem G, Pien K, Hubloue I, Lauwaert I, van Lier T, Annemans L, Putman K.

Injury. 2017 Oct;48(10):2132-2139. doi: 10.1016/j.injury.2017.08.009. Epub 2017 Aug 5.

PMID:
28838595
43.

Applying Quality Indicators For Administrative Databases To Evaluate End-Of-Life Care For Cancer Patients In Belgium.

De Schreye R, Smets T, Annemans L, Deliens L, Gielen B, De Gendt C, Cohen J.

Health Aff (Millwood). 2017 Jul 1;36(7):1234-1243. doi: 10.1377/hlthaff.2017.0199.

PMID:
28679810
44.

Health and budget impact of combined HIV prevention - first results of the BELHIVPREV model.

Vermeersch S, Callens S, De Wit S, Goffard JC, Laga M, Van Beckhoven D, Annemans L.

Acta Clin Belg. 2018 Feb;73(1):54-67. doi: 10.1080/17843286.2017.1339978. Epub 2017 Jul 3.

PMID:
28673201
45.

Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.

Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, Morton RL, Oberbauer R, Postma MJ, Tonelli M, Biesen WV, Zoccali C; European Kidney Health Alliance.

Nat Rev Nephrol. 2017 Jul;13(7):393-409. doi: 10.1038/nrneph.2017.63. Epub 2017 May 30. Review.

PMID:
28555652
46.

Economic consequences of legal and illegal drugs: The case of social costs in Belgium.

Lievens D, Vander Laenen F, Verhaeghe N, Putman K, Pauwels L, Hardyns W, Annemans L.

Int J Drug Policy. 2017 Jun;44:50-57. doi: 10.1016/j.drugpo.2017.03.005. Epub 2017 Apr 23.

PMID:
28445835
47.

HTA programme response to the challenges of dealing with orphan medicinal products: Process evaluation in selected European countries.

Nicod E, Annemans L, Bucsics A, Lee A, Upadhyaya S, Facey K.

Health Policy. 2019 Feb;123(2):140-151. doi: 10.1016/j.healthpol.2017.03.009. Epub 2017 Mar 28.

48.

Association Between Clinical Pathways Leading to Medical Management and Prognosis in Patients With NSTEACS.

Bueno H, Pocock S, Medina J, Danchin N, Annemans L, Licour M, Gregson J, Vega AM, van de Werf F.

Rev Esp Cardiol (Engl Ed). 2017 Oct;70(10):817-824. doi: 10.1016/j.rec.2016.12.031. Epub 2017 Mar 11. English, Spanish.

49.

Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL).

Annemans L, Aymé S, Le Cam Y, Facey K, Gunther P, Nicod E, Reni M, Roux JL, Schlander M, Taylor D, Tomino C, Torrent-Farnell J, Upadhyaya S, Hutchings A, Le Dez L.

Orphanet J Rare Dis. 2017 Mar 10;12(1):50. doi: 10.1186/s13023-017-0601-9.

50.

Modified Rankin scale as a determinant of direct medical costs after stroke.

Dewilde S, Annemans L, Peeters A, Hemelsoet D, Vandermeeren Y, Desfontaines P, Brouns R, Vanhooren G, Cras P, Michielsens B, Redondo P, Thijs V.

Int J Stroke. 2017 Jun;12(4):392-400. doi: 10.1177/1747493017691984. Epub 2017 Feb 6.

PMID:
28164742

Supplemental Content

Loading ...
Support Center